artenimol has been researched along with fluorouracil in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Deng, T; Fan, ML; Liu, JH; Lv, WB; Xu, CC; Yu, BY | 1 |
| Liu, Y; Xu, Z; Zhao, SJ | 1 |
| Chaijaroenkul, W; Mahavorasirikul, W; Na-Bangchang, K; Viyanant, V | 1 |
| Bhandari, A; Chen, R; Pan, Y; Wang, O; Wang, Y; Xia, E; Yang, F; Yao, Z | 1 |
1 review(s) available for artenimol and fluorouracil
| Article | Year |
|---|---|
1,2,3-Triazole-containing hybrids as potential anticancer agents: Current developments, action mechanisms and structure-activity relationships.
Topics: Antineoplastic Agents; Humans; Molecular Structure; Neoplasms; Structure-Activity Relationship; Triazoles | 2019 |
3 other study(ies) available for artenimol and fluorouracil
| Article | Year |
|---|---|
Synthesis and in vitro antitumor evaluation of dihydroartemisinin-cinnamic acid ester derivatives.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Artemisinins; Cell Line, Tumor; Chemistry Techniques, Synthetic; Cinnamates; Drug Screening Assays, Antitumor; Humans; Iron; Oxidative Stress; Reactive Oxygen Species | 2016 |
Cytotoxic activity of artemisinin derivatives against cholangiocarcinoma (CL-6) and hepatocarcinoma (Hep-G2) cell lines.
Topics: Antigens, CD; Antineoplastic Agents; Artemisinins; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carcinoma, Hepatocellular; Cell Line, Tumor; Cholangiocarcinoma; Drug Resistance, Neoplasm; Fluorouracil; Gene Expression; Humans; Liver Neoplasms; Receptors, Transferrin; Transferrin | 2011 |
Dihydroartemisinin potentiates antitumor activity of 5-fluorouracil against a resistant colorectal cancer cell line.
Topics: Antimalarials; Antimetabolites, Antineoplastic; Apoptosis; Artemisinins; Colorectal Neoplasms; Drug Resistance, Neoplasm; Drug Synergism; Fluorouracil; HCT116 Cells; Humans; Reactive Oxygen Species | 2018 |